News Focus
News Focus
Post# of 257375
Next 10
Followers 1
Posts 465
Boards Moderated 0
Alias Born 10/21/2003

Re: None

Friday, 12/31/2004 1:50:15 AM

Friday, December 31, 2004 1:50:15 AM

Post# of 257375
I had previously mentioned SNMX. While researching a new lot of biotechs for potential purchase I ran across this company. I like biotech companies that have platforms for mutiple apps, DNDN casette for example. Here's one that is outside cancer to boot. [another big plus IMHO]

As I posted before Nature Biotechnology confirms SNMX
IP moat as quite large in the area of flavor enhancers.

In essence they are using human taste receptors and high speed screen assays to find new products in comparison to limited taste throughput of human panels. Re: 200,000 at a whack versus IF&F human panels in the low 1000's.

Highly recommend listening to their last investors conference at:

http://tinyurl.com/58jsl

Maybe share some viewpoints.

Positives appear to be:

Agreements with major food processors: Campbells, Coke,Nestle.

Low number of shares of stock.

Steady burn rate with aparent ample funds until milestones & royalties kick in. [No immediate dilution]

Use of GRAS to get product candidates to market fast.

Different product lines (royalty streams) for same flavor compound.

What could go wrong here?

I've bought a small amount & sent off for the investors package . In the meantime discussion is welcome.


Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today